A European partner in life science
Our vision is to improve people's lives by being a leading, value-adding partner in life science
INTERIM REPORT Q2 2024
Share price
Press Releases
Report
Calendar
-
Good growth in both Business Areas and continued profitability improvement
comments by the ceoThe companies within AddLife showed strong performance development during the quarter. In Labtech, sales growth recovered as expected and margins remained stable. Sales growth in Medtech was good and margins improved partly driven by restructuring efforts that are now yielding clear results. Cash flow improved significantly and after the end of the quarter, an acquisition was made in line with our updated long-term strategy.
![Fredrik Dalborg Q2 2024 VD Addlife]()
-
AddLife acquires BonsaiLab
To BonsailabBonsaiLab is a leading Spanish distributor in the field of cell and molecular biology. The company’s offering includes cutting-edge technology products, analytical solutions, and services for genomics laboratories in Spain and Portugal, including products for next generation sequencing, genomic analysis as well as sample preparation. The company, with current revenues of EUR 8 m, has 13 employees and will be included in AddLife’s business area Labtech.
![Adobestock 670238669]()
-
Improving people´s lives
Improving people´s lives YoutubeWe have the perfect vision. We want to improve people's lives by being a leading, value-adding partner in Life Science. See our movie here:
![Improving Peoples Lives Youtube]()
Our business areas
MEDTECH
In the Medtech business area, the subsidiaries offer products and services in the field of medical technology, as well as assistive equipment for use in homecare. Medtech’s offering mainly focuses on public funded health care, homecare and social care in Europe.
Read more
LABTECH
The Labtech business area provides products, solutions and services in fields such as diagnostics, biomedical research and laboratory analysis. Customers include hospitals, research laboratories, pharmaceutical companies, and food industry groups, primarily in the Nordics and rest of Europe.
Read moreJoin the AddLife group
Do you have a life science company with opportunities to grow? We offer an attractive option with a decentralized business model where we combine the strength of a large enterprise with the dedication and business skills of an entrepreneur. As an AddLife subsidiary you are responsible for your business activities within the AddLife requirements for growth, profitability and sustainable development.
News from our subsidiaries
BioMedicas´s cultural diversity contributes to its sustainable growth.
Euroclone has decided to replace the traditional cooling elements with eco-sustainable RecyCold bags. These bags are recyclable, reusable and made from biodegradable materials, making them the ideal eco-friendly choice for the biotech industry. RecyCold bags are made of paper and contain a completely biodegradable plant-based gel. Once used, the gel can be disposed of in the sink without environmental impact, while the paper bag is easily recyclable. These bags maintain temperatures from -2 to -5 °C and 2 to 8 °C for over 48 hours, ensuring the quality of our shipments. Why is this choice is so important: we use over 10,000 coolers per year, so our commitment to the environment will significantly impact sustainability. A small gesture that makes a big difference! 🌍
AddLife´s decentralized business model fosters agility, rapid decision-making, and efficient operations in local markets
Svancare furnishes with height adjustable toilets and basins from Ropox and Korpien.
Sustainability for AddLife
Sustainability is a central part of AddLife's vision to improve people's life by being a leading, value adding provider in life science. AddLife´s approach to sustainability is identified through three impact areas where we can have the greatest contribution to a long-term lasting business and society.
